Soluble intercellular adhesion molecule-1 and Graves' disease.
Escobar-Morreale
H F
HF
Serrano
J
J
Sancho
J M
JM
Varela
C
C
D000293:Adolescent; D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006111:Graves Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D008297:Male; D008713:Methimazole / Q000627:therapeutic use*; D008875:Middle Aged; D011379:Prognosis; D011446:Prospective Studies; D012008:Recurrence; D013974:Thyroxine / Q000627:therapeutic use; D016896:Treatment Outcome
D013956:Antithyroid Agents; D018799:Intercellular Adhesion Molecule-1; D008713:Methimazole; D013974:Thyroxine